Press Releases Novo Nordisk’s $50 billion in Ozempic & Wegovy Sales Comes at the Expense of Healthcare Solvency August 7, 2024
Press Releases Public Citizen Urges HHS to Unlock Generic Competition for Popular Weight Loss Drugs Ozempic and Wegovy August 5, 2024
Letters, Testimony & Filings Public Citizen Petitions HHS to License Generic Competition on Ozempic and Wegovy
Letters, Testimony & Filings Public Citizen Comments to NIH on Proposed Access Planning Policy July 23, 2024
Letters, Testimony & Filings Public Interest Groups Submit Comments to NIH on Proposed Access Planning Policy July 23, 2024
Letters, Testimony & Filings Public Citizen Comments to USPTO on Proposed Rule Changing Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting July 9, 2024